Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#61 / 99 Total
BLRX - Bioline Rx Ltd ADR - Stock Price Chart
TickerBLRX [NASD]
CompanyBioline Rx Ltd ADR
CountryIsrael
IndustryBiotechnology
Market Cap48.89MEPS (ttm)-0.95
P/E-EPS this Y-15.02%
Forward P/E-EPS next Y9.71%
PEG-EPS past 5Y21.53%
P/S10.19EPS next 5Y-
P/B3.35EPS Q/Q-105.91%
Dividend-Sales Q/Q-
Insider Own0.56%Inst Own1.60%
Insider Trans0.00%Inst Trans128.85%
Short Float0.99%EarningsMar 26/b
Analyst Recom1.00Target Price13.75
Avg Volume422.40K52W Range0.56 - 2.53
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors. The company was founded in 2003 and is headquartered in Modi'in, Israel.
NTLA - Intellia Therapeutics Inc - Stock Price Chart
TickerNTLA [NASD, RUT]
CompanyIntellia Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap2.00BEPS (ttm)-5.42
P/E-EPS this Y-2.45%
Forward P/E-EPS next Y-1.53%
PEG-EPS past 5Y-22.30%
P/S55.20EPS next 5Y30.00%
P/B1.84EPS Q/Q-4.64%
Dividend-Sales Q/Q-114.12%
Insider Own2.33%Inst Own88.48%
Insider Trans-2.33%Inst Trans-0.30%
Short Float15.49%EarningsFeb 22/b
Analyst Recom1.54Target Price69.57
Avg Volume1.54M52W Range19.64 - 47.48
Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BASTA JAMESEVP, General CounselMar 04 '24Sale32.992,29775,77881,571Mar 05 04:10 PM
Clark ElianaEVP, Chief Technical OfficerMar 04 '24Sale32.9960519,95971,470Mar 05 04:10 PM
Sepp-Lorenzino LauraEVP, Chief Scientific OfficerJan 08 '24Sale28.872,27565,68243,927Jan 10 04:15 PM
LEONARD JOHN MPresident and CEOJan 03 '24Sale29.4619,223566,310846,486Jan 05 04:51 PM
Lebwohl DavidEVP, Chief Medical OfficerJan 03 '24Sale29.465,843172,13554,372Jan 05 04:50 PM
HURC - Hurco Companies, Inc. - Stock Price Chart
TickerHURC [NASD]
CompanyHurco Companies, Inc.
CountryUSA
IndustrySpecialty Industrial Machinery
Market Cap120.24MEPS (ttm)0.21
P/E87.95EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-26.80%
P/S0.55EPS next 5Y-
P/B0.54EPS Q/Q-228.32%
Dividend3.47%Sales Q/Q-17.60%
Insider Own7.65%Inst Own71.84%
Insider Trans0.00%Inst Trans-1.39%
Short Float0.20%EarningsJan 05/b
Analyst Recom3.00Target Price38.00
Avg Volume26.76K52W Range18.45 - 28.20
Hurco Cos., Inc. is an international industrial technology company, which engages in the design, manufacture, and sale of computerized machine tools. It also offers machine tool components, software options, control upgrades, and accessories and replacement parts for its products, as well as customer service and training and applications support. The company was founded by Edward Humston and Gerald V. Roch in 1968 and is headquartered in Indianapolis, IN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DOAR MICHAELExecutive ChairmanSep 20 '23Buy21.599,200198,628183,150Sep 20 05:17 PM
Wright Jonathon D.General Counsel/Corp SecretarySep 18 '23Buy21.634609,9503,621Sep 19 03:25 PM
Porter Richard R.DirectorSep 18 '23Sale21.602,43052,48810,573Sep 19 03:26 PM
Volovic Gregory SPresident & CEOSep 15 '23Buy21.302,35750,20476,651Sep 15 06:27 PM
Jamison HaiQuynhCorporate ControllerSep 15 '23Buy21.274619,8053,627Sep 15 05:27 PM
CLIR - ClearSign Technologies Corp - Stock Price Chart
TickerCLIR [NASD]
CompanyClearSign Technologies Corp
CountryUSA
IndustryPollution & Treatment Controls
Market Cap28.89MEPS (ttm)-0.13
P/E-EPS this Y15.38%
Forward P/E24.67EPS next Y127.27%
PEG-EPS past 5Y20.15%
P/S12.04EPS next 5Y-
P/B5.51EPS Q/Q28.82%
Dividend-Sales Q/Q2448.00%
Insider Own16.98%Inst Own7.31%
Insider Trans0.00%Inst Trans2.40%
Short Float0.96%EarningsApr 23/a
Analyst Recom1.00Target Price6.00
Avg Volume62.84K52W Range0.75 - 1.75
ClearSign Technologies Corp. engages in the design and development of technologies for the combustion systems. Its product Duplex technology focuses on the performance enhancement of combustion systems in a broad range of markets, including the energy, commercial and industrial boiler, chemical, petrochemical, and power industries. The company was founded by Richard F. Rutkowski, David B. Goodson, and Geoffrey D. Osler on January 23, 2008 and is headquartered in Tulsa, OK.
FOA - Finance of America Companies Inc - Stock Price Chart
TickerFOA [NYSE, RUT]
CompanyFinance of America Companies Inc
CountryUSA
IndustryCredit Services
Market Cap47.61MEPS (ttm)-1.34
P/E-EPS this Y-108.84%
Forward P/E1.58EPS next Y981.10%
PEG-EPS past 5Y-528.03%
P/S1.55EPS next 5Y-
P/B0.20EPS Q/Q129.66%
Dividend-Sales Q/Q-69.36%
Insider Own69.61%Inst Own20.75%
Insider Trans0.00%Inst Trans-0.17%
Short Float3.72%EarningsMar 06/a
Analyst Recom1.50Target Price1.75
Avg Volume89.34K52W Range0.46 - 2.09
Finance of America Cos. Inc. engages in the provision of mortgage loans, reverse mortgage loans, and business purpose loans to residential real estate investors. It offers a vertically integrated lending and services platform that connects borrowers with investors. The company was founded on October 9, 2020 and is headquartered in Plano, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sieffert Kristen NPresidentApr 01 '24Option Exercise0.00360,6980565,216Apr 03 04:42 PM
Thornock Tai A.Chief Accounting OfficerApr 01 '24Option Exercise0.0084,4940149,255Apr 03 04:38 PM
Richmond LaurenChief Legal OfficerApr 01 '24Option Exercise0.0095,1810198,480Apr 03 04:36 PM
Prahm JeremyChief Investment OfficerApr 01 '24Option Exercise0.00772,49201,115,176Apr 03 04:34 PM
Fleming GrahamChief Executive OfficerApr 01 '24Option Exercise0.00892,89301,401,158Apr 03 04:32 PM
BCOV - Brightcove Inc - Stock Price Chart
TickerBCOV [NASD, RUT]
CompanyBrightcove Inc
CountryUSA
IndustrySoftware - Application
Market Cap71.25MEPS (ttm)-0.53
P/E-EPS this Y-100.00%
Forward P/E-EPS next Y87.50%
PEG-EPS past 5Y-6.25%
P/S0.35EPS next 5Y15.00%
P/B0.76EPS Q/Q54.89%
Dividend-Sales Q/Q1.86%
Insider Own7.25%Inst Own81.35%
Insider Trans8.47%Inst Trans0.16%
Short Float4.09%EarningsMay 08/a
Analyst Recom2.00Target Price4.00
Avg Volume229.88K52W Range1.57 - 4.56
Brightcove, Inc. engages in the provision of video cloud solutions. The firm enables its customers to publish and distribute video to Internet-connected devices. Its products include Brightcove Video Cloud, Brightcove Live, Brightcove Beacon, Brightcove Player, Zencoder, and Brightcove Audience Insights. The company was founded by Jeremy J. Allaire and Robert Mason in August 2004 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Edenbrook Capital, LLC10% OwnerApr 16 '24Buy1.6946,83179,1076,512,633Apr 17 04:10 PM
Edenbrook Capital, LLC10% OwnerApr 15 '24Buy1.6810,00016,7506,465,802Apr 17 04:10 PM
Edenbrook Capital, LLC10% OwnerApr 12 '24Buy1.706,35110,7976,455,802Apr 12 04:27 PM
Edenbrook Capital, LLC10% OwnerApr 11 '24Buy1.783,8246,7906,449,451Apr 12 04:27 PM
Edenbrook Capital, LLC10% OwnerApr 10 '24Buy1.805,0008,9996,445,627Apr 12 04:27 PM
EGRX - Eagle Pharmaceuticals Inc - Stock Price Chart
TickerEGRX [NASD, RUT]
CompanyEagle Pharmaceuticals Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap54.04MEPS (ttm)0.91
P/E4.57EPS this Y-
Forward P/E-EPS next Y-
PEG1.69EPS past 5Y-3.56%
P/S0.21EPS next 5Y2.70%
P/B0.22EPS Q/Q153.33%
Dividend-Sales Q/Q-12.80%
Insider Own12.02%Inst Own86.94%
Insider Trans-1.37%Inst Trans-1.44%
Short Float10.30%EarningsNov 16/b
Analyst Recom3.00Target Price17.00
Avg Volume181.79K52W Range4.10 - 30.40
Apr-15-24 07:00AM Eagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Response of Amisulpride for the Rescue Treatment of Postoperative Nausea and Vomiting (PONV) at the Upcoming ASPAN 2024 National Conference in Orlando, Florida (GlobeNewswire) +13.29%
Apr-12-24 04:05PM Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K (GlobeNewswire)
Feb-05-24 09:55AM Eagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on Lender Agreement - Hagens Berman (GlobeNewswire)
Feb-01-24 04:05PM Eagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on Lender Agreement - Hagens Berman (GlobeNewswire)
Jan-26-24 12:33PM EGRX STOCKHOLDERS: Robbins LLP Reminds Eagle Pharmaceuticals Shareholders of Pending Lead Plaintiff Deadline February 9, 2024 (GlobeNewswire)
Jan-24-24 09:45AM EAGLE PHARMACEUTICALS SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options (GlobeNewswire)
Jan-18-24 06:50AM Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfolio (GlobeNewswire)
Jan-12-24 10:12AM Eagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on Lender Agreement - Hagens Berman (GlobeNewswire)
Jan-10-24 10:00AM EAGLE PHARMACEUTICALS SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options (GlobeNewswire)
Jan-08-24 05:43PM Eagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on Lender Agreement - Hagens Berman (GlobeNewswire)
Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. Its products include RYANODEX, BENDEKA and BELRAPZO. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tarriff ScottCEONov 02 '23Sale13.8710,694148,326545,447Nov 03 04:39 PM
Tarriff ScottCEONov 01 '23Sale13.8210,925150,984556,141Nov 03 04:39 PM
Graves MichaelDirectorOct 27 '23Option Exercise4.949,36046,23810,360Oct 31 05:41 PM
Tarriff ScottCEOOct 03 '23Sale14.4610,734155,174567,066Oct 04 05:07 PM
Tarriff ScottCEOOct 02 '23Sale15.239,511144,853577,800Oct 04 05:07 PM
BNAI - Brand Engagement Network Inc - Stock Price Chart
TickerBNAI [NASD]
CompanyBrand Engagement Network Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap88.96MEPS (ttm)-0.00
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.12EPS Q/Q-197.91%
Dividend-Sales Q/Q-
Insider Own54.10%Inst Own5.82%
Insider Trans0.00%Inst Trans5.84%
Short Float0.11%Earnings-
Analyst Recom-Target Price-
Avg Volume82.57K52W Range2.50 - 19.75
Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is headquartered in Jackson, WY.
VIGL - Vigil Neuroscience Inc - Stock Price Chart
TickerVIGL [NASD, RUT]
CompanyVigil Neuroscience Inc
CountryUSA
IndustryBiotechnology
Market Cap101.84MEPS (ttm)-2.13
P/E-EPS this Y-8.33%
Forward P/E-EPS next Y-0.60%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.84EPS Q/Q-19.06%
Dividend-Sales Q/Q-
Insider Own60.34%Inst Own33.92%
Insider Trans0.02%Inst Trans28.85%
Short Float6.18%EarningsMar 26/b
Analyst Recom1.50Target Price16.75
Avg Volume88.45K52W Range2.53 - 11.11
Vigil Neuroscience, Inc. engages in the provision of biotechnology research services. Its focus is improving the lives of patients, caregivers, and families affected by neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. The company was founded on June 22, 2020 and is headquartered in Watertown, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Magovcevic-Liebisch IvanaPresident and CEONov 20 '23Buy3.754,00015,000207,687Nov 20 06:34 PM
SHEN - Shenandoah Telecommunications Co. - Stock Price Chart
TickerSHEN [NASD, RUT]
CompanyShenandoah Telecommunications Co.
CountryUSA
IndustryTelecom Services
Market Cap675.53MEPS (ttm)0.16
P/E84.59EPS this Y-133.75%
Forward P/E-EPS next Y-103.70%
PEG3.47EPS past 5Y-29.82%
P/S2.35EPS next 5Y24.40%
P/B1.03EPS Q/Q239.94%
Dividend0.75%Sales Q/Q3.57%
Insider Own15.78%Inst Own57.32%
Insider Trans0.00%Inst Trans-1.03%
Short Float2.07%EarningsFeb 21/b
Analyst Recom2.50Target Price26.00
Avg Volume150.97K52W Range13.48 - 25.51
Shenandoah Telecommunications Co. is a holding company, which engages in the provision of regulated and unregulated telecommunication services to end-user customers and other telecommunications providers. It offers voice, video and data communications services. It operates through the Broadband and Tower segments. The Broadband segment provides broadband, video, and voice services to residential and commercial customers in portions of Virginia, West Virginia, Maryland, and Kentucky, via fiber optic and hybrid fiber coaxial ("HFC") cable. The Tower segment leases space on 225 owned cell towers. The company was founded in 1902 and is headquartered in Edinburg, VA.
12345678910